Stereotactic radiation therapy of renal cancer inferior vena cava tumor thrombus

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29; PMID:24399786; http://dx.doi.org/10.3322/caac.21208
   PubMed Web of Science ®Google Scholar
• Chow WH, Dong LM, Devesa SS. Epidemiology and risk factors for kidney cancer. Nat Rev Urol 2010; 7:245-57; PMID:20448658; http://dx.doi.org/10.1038/nrurol.2010.46
   PubMed Web of Science ®Google Scholar
• Kim HL, Zisman A, Han KR, Figlin RA, Belldegrun AS. Prognostic significance of venous thrombus in renal cell carcinoma. Are renal vein and inferior vena cava involvement different? J Urol 2004; 171:588-91; PMID:14713765; http://dx.doi.org/10.1097/01.ju.0000104672.37029.4b
   PubMed Web of Science ®Google Scholar
• Lawindy SM, Kurian T, Kim T, Mangar D, Armstrong PA, Alsina AE, Sheffield C, Sexton WJ, Spiess PE. Important surgical considerations in the management of renal cell carcinoma (RCC) with inferior vena cava (IVC) tumour thrombus. BJU Int 2012; 110:926-39; PMID:22540179; http://dx.doi.org/10.1111/j.1464-410X.2012.11174.x
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC; European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 2010; 58:398-406; PMID:20633979; http://dx.doi.org/10.1016/j.eururo.2010.06.032
   PubMed Web of Science ®Google Scholar
• Neves RJ, Zincke H. Surgical treatment of renal cancer with vena cava extension. Br J Urol 1987; 59:390-5; PMID:3594097; http://dx.doi.org/10.1111/j.1464-410X.1987.tb04832.x
   PubMedGoogle Scholar
• Haddad AQ, Wood CG, Abel EJ, Krabbe LM, Darwish OM, Thompson RH, Heckman JE, Merril MM, Gayed BA, Sagalowsky AI, et al. Oncologic outcomes following surgical resection of renal cell carcinoma with inferior vena caval thrombus extending above the hepatic veins: a contemporary multicenter cohort. J Urol 2014; 192:1050-6; PMID:24704115; http://dx.doi.org/10.1016/j.juro.2014.03.111
   PubMed Web of Science ®Google Scholar
• Abel EJ, Thompson RH, Margulis V, Heckman JE, Merril MM, Darwish OM, Krabbe LM, Boorjian SA, Leibovich BC, Wood CG. Perioperative outcomes following surgical resection of renal cell carcinoma with inferior vena cava thrombus extending above the hepatic veins: a contemporary multicenter experience. Eur Urol 2014; 66:584-92; PMID:24262104; http://dx.doi.org/10.1016/j.eururo.2013.10.029
   PubMed Web of Science ®Google Scholar
• Deschavanne PJ, Fertil B. A review of human cell radiosensitivity in vitro. Int J Radiat Oncol Biol Phys 1996; 34:251-66; PMID:12118559; http://dx.doi.org/10.1016/0360-3016(95)02029-2
   PubMed Web of Science ®Google Scholar
• Ning S, Trisler K, Wessels BW, Knox SJ. Radiobiologic studies of radioimmunotherapy and external beam radiotherapy in vitro and in vivo in human renal cell carcinoma xenografts. Cancer 1997; 80:2519-28; PMID:9406705; http://dx.doi.org/10.1002/(SICI)1097-0142(19971215)80:12+%3c2519::AID-CNCR26%3e3.0.CO;2-E
   PubMed Web of Science ®Google Scholar
• Walsh L, Stanfield JL, Cho LC, Chang CH, Forster K, Kabbani W, Cadeddu JA, Hsieh JT, Choy H, Timmerman R, et al. Efficacy of ablative high-dose-per-fraction radiation for implanted human renal cell cancer in a nude mouse model. Eur Urol 2006; 50:795-800; discussion 800; PMID:16632182; http://dx.doi.org/10.1016/j.eururo.2006.03.021
   PubMed Web of Science ®Google Scholar
• De Meerleer G, Khoo V, Escudier B, Joniau S, Bossi A, Ost P, Briganti A, Fonteyne V, Van Vulpen M, Lumen N, et al. Radiotherapy for renal-cell carcinoma. Lancet Oncol 2014; 15:e170-7; PMID:24694640; http://dx.doi.org/10.1016/S1470-2045(13)70569-2
   PubMed Web of Science ®Google Scholar
• Sivaramakrishna B, Gupta NP, Wadhwa P, Hemal AK, Dogra PN, Seth A, Aron M, Kumar R. Pattern of metastases in renal cell carcinoma: a single institution study. Indian J Cancer 2005; 42:173-7; PMID:16391434
   PubMedGoogle Scholar
• Kroeger N, Xie W, Lee JL, et al: Metastatic non-clear cell renal cell carcinoma treated with targeted therapy agents: characterization of survival outcome and application of the International mRCC Database Consortium criteria. Cancer 2013; 119:2999-3006.
   PubMed Web of Science ®Google Scholar
• Boike TP, Lotan Y, Cho LC, Brindle J, DeRose P, Xie XJ, Yan J, Foster R, Pistenmaa D, Perkins A, et al. Phase I dose-escalation study of stereotactic body radiation therapy for low- and intermediate-risk prostate cancer. J Clin Oncol 2011; 29:2020-6; PMID:21464418; http://dx.doi.org/10.1200/JCO.2010.31.4377
   PubMed Web of Science ®Google Scholar
• Timmerman R, Paulus R, Galvin J, Michalski J, Straube W, Bradley J, Fakiris A, Bezjak A, Videtic G, Johnstone D, et al. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA 2010; 303:1070-6; PMID:20233825; http://dx.doi.org/10.1001/jama.2010.261
   PubMed Web of Science ®Google Scholar
• King CR, Freeman D, Kaplan I, Fuller D, Bolzicco G, Collins S, Meier R, Wang J, Kupelian P, Steinberg M, et al. Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials. Radiother Oncol 2013; 109(2):217-21
   PubMed Web of Science ®Google Scholar
• Katz AJ, Santoro M, Diblasio F, Ashley R. Stereotactic body radiotherapy for localized prostate cancer: disease control and quality of life at 6 years. Radiat Oncol 2013; 8:118; PMID:23668632; http://dx.doi.org/10.1186/1748-717X-8-118
   PubMed Web of Science ®Google Scholar
• Timmerman RD, Kavanagh BD, Cho LC, Papiez L, Xing L. Stereotactic body radiation therapy in multiple organ sites. J Clin Oncol 2007; 25:947-52; PMID:17350943; http://dx.doi.org/10.1200/JCO.2006.09.7469
   PubMed Web of Science ®Google Scholar
• Berber B, Sanabria JR, Braun K, Yao M, Ellis RJ, Kunos CA, Sohn J, Machtay M, Teh BS, Huang Z, et al. Emerging role of stereotactic body radiotherapy in the treatment of pancreatic cancer. Expert Rev Anticancer Ther 2013; 13:481-7; PMID:23560842; http://dx.doi.org/10.1586/era.13.19
   PubMed Web of Science ®Google Scholar
• Tao C, Yang LX. Improved radiotherapy for primary and secondary liver cancer: stereotactic body radiation therapy. Anticancer Res 2012; 32:649-55; PMID:22287758
   PubMed Web of Science ®Google Scholar
• Kwon JH, Bae SH, Kim JY, Choi BO, Jang HS, Jang JW, Choi JY, Yoon SK, Chung KW. Long-term effect of stereotactic body radiation therapy for primary hepatocellular carcinoma ineligible for local ablation therapy or surgical resection. Stereotactic radiotherapy for liver cancer. BMC Cancer 2010; 10:475; PMID:20813065; http://dx.doi.org/10.1186/1471-2407-10-475
   PubMed Web of Science ®Google Scholar
• Bondiau PY, Courdi A, Bahadoran P, Chamorey E, Queille-Roussel C, Lallement M, Birtwisle-Peyrottes I, Chapellier C, Pacquelet-Cheli S, Ferrero JM. Phase 1 clinical trial of stereotactic body radiation therapy concomitant with neoadjuvant chemotherapy for breast cancer. Int J Radiat Oncol Biol Phys 2013; 85:1193-9; PMID:23332384; http://dx.doi.org/10.1016/j.ijrobp.2012.10.034
   PubMed Web of Science ®Google Scholar
• Chang BK, Timmerman RD. Stereotactic body radiation therapy: a comprehensive review. Am J Clin Oncol 2007; 30:637-44; PMID:18091059; http://dx.doi.org/10.1097/COC.0b013e3180ca7cb1
   PubMed Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Teh BS, Cardenes HR, Henderson MA, Forquer JA, Papiez L, McGarry RC, Wang JZ, Li K, et al. Stereotactic body radiation therapy for oligometastases. Expert Rev Anticancer Ther 2009; 9:621-35; PMID:19445579; http://dx.doi.org/10.1586/era.09.15
   PubMed Web of Science ®Google Scholar
• Lo SS, Fakiris AJ, Chang EL, Mayr NA, Wang JZ, Papiez L, Teh BS, McGarry RC, Cardenes HR, Timmerman RD. Stereotactic body radiation therapy: a novel treatment modality. Nat Rev Clin Oncol 2010; 7:44-54; PMID:19997074; http://dx.doi.org/10.1038/nrclinonc.2009.188
   PubMed Web of Science ®Google Scholar
• Blanco AI, Teh BS, Amato RJ. Role of radiation therapy in the management of renal cell cancer. Cancers (Basel) 2011; 3:4010-23; PMID:24213122; http://dx.doi.org/10.3390/cancers3044010
   PubMedGoogle Scholar
• Shuto T, Matsunaga S, Suenaga J, Inomori S, Fujino H. Treatment strategy for metastatic brain tumors from renal cell carcinoma: selection of gamma knife surgery or craniotomy for control of growth and peritumoral edema. J Neurooncol 2010; 98:169-75; PMID:20405309; http://dx.doi.org/10.1007/s11060-010-0170-4
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Welch WC. Radiosurgery for spinal metastases: clinical experience in 500 cases from a single institution. Spine (Phila Pa 1976) 2007; 32:193-9; http://dx.doi.org/10.1097/01.brs.0000251863.76595.a2
   PubMed Web of Science ®Google Scholar
• Gerszten PC, Burton SA, Ozhasoglu C, Vogel WJ, Welch WC, Baar J, Friedland DM. Stereotactic radiosurgery for spinal metastases from renal cell carcinoma. J Neurosurg Spine 2005; 3:288-95; PMID:16266070; http://dx.doi.org/10.3171/spi.2005.3.4.0288
   PubMed Web of Science ®Google Scholar
• Yamada Y, Bilsky MH, Lovelock DM, Venkatraman ES, Toner S, Johnson J, Zatcky J, Zelefsky MJ, Fuks Z. High-dose, single-fraction image-guided intensity-modulated radiotherapy for metastatic spinal lesions. Int J Radiat Oncol Biol Phys 2008; 71:484-90; PMID:18234445; http://dx.doi.org/10.1016/j.ijrobp.2007.11.046
   PubMed Web of Science ®Google Scholar
• Nguyen QN, Shiu AS, Rhines LD, Wang H, Allen PK, Wang XS, Chang EL. Management of spinal metastases from renal cell carcinoma using stereotactic body radiotherapy. Int J Radiat Oncol Biol Phys 2010; 76:1185-92; PMID:19632064; http://dx.doi.org/10.1016/j.ijrobp.2009.03.062
   PubMed Web of Science ®Google Scholar
• Ranck MC, Golden DW, Corbin KS, Hasselle MD, Liauw SL, Stadler WM, Hahn OM, Weichselbaum RR, Salama JK. Stereotactic Body Radiotherapy for the Treatment of Oligometastatic Renal Cell Carcinoma. Am J Clin Oncol 2012; 36(6):589-95
   Web of Science ®Google Scholar
• Wersall PJ, Blomgren H, Lax I, Linder C, Lundell G, Nilsson B, Nilsson S, Näslund I, Pisa P, Svedman C. Extracranial stereotactic radiotherapy for primary and metastatic renal cell carcinoma. Radiother Oncol 2005; 77:88-95; PMID:15972239; http://dx.doi.org/10.1016/j.radonc.2005.03.022
   PubMed Web of Science ®Google Scholar
• Beitler JJ, Makara D, Silverman P, Lederman G. Definitive, high-dose-per-fraction, conformal, stereotactic external radiation for renal cell carcinoma. Am J Clin Oncol 2004; 27:646-8; PMID:15577450; http://dx.doi.org/10.1097/01.coc.0000145289.57705.07
   PubMed Web of Science ®Google Scholar
• Wotkowicz C, Wszolek MF, Libertino JA. Resection of renal tumors invading the vena cava. Urol Clin North Am 2008; 35:657-71; viii; PMID:18992619; http://dx.doi.org/10.1016/j.ucl.2008.07.013
   PubMed Web of Science ®Google Scholar
• Hou JZ, Zeng ZC, Zhang JY, Fan J, Zhou J, Zeng MS. Influence of tumor thrombus location on the outcome of external-beam radiation therapy in advanced hepatocellular carcinoma with macrovascular invasion. Int J Radiat Oncol Biol Phys 2012; 84:362-8; PMID:22381903; http://dx.doi.org/10.1016/j.ijrobp.2011.12.024
   PubMed Web of Science ®Google Scholar
• Xi M, Zhang L, Zhao L, Li QQ, Guo SP, Feng ZZ, Deng XW, Huang XY, Liu MZ. Effectiveness of stereotactic body radiotherapy for hepatocellular carcinoma with portal vein and/or inferior vena cava tumor thrombosis. PLoS One 2013; 8:e63864; PMID:23737955; http://dx.doi.org/10.1371/journal.pone.0063864
   PubMed Web of Science ®Google Scholar